Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast.
about
Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Treatment of obesity-associate ...... type-4 inhibitor roflumilast.
@en
Treatment of obesity-associate ...... type-4 inhibitor roflumilast.
@nl
type
label
Treatment of obesity-associate ...... type-4 inhibitor roflumilast.
@en
Treatment of obesity-associate ...... type-4 inhibitor roflumilast.
@nl
prefLabel
Treatment of obesity-associate ...... type-4 inhibitor roflumilast.
@en
Treatment of obesity-associate ...... type-4 inhibitor roflumilast.
@nl
P2093
P2860
P1476
Treatment of obesity-associate ...... type-4 inhibitor roflumilast.
@en
P2093
P2860
P304
P356
10.1007/S11255-017-1671-2
P577
2017-07-29T00:00:00Z